Armata Pharmaceuticals Stock Price

-0.11 (-2.55%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Armata Pharmaceuticals Inc ARMP AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.11 -2.55% 4.20 16:15:00
Open Price Low Price High Price Close Price Prev Close
4.48 4.15 4.48 4.20 4.31
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
101 6,536 $ 4.30 $ 28,131 28,748 2.56 - 10.48
Last Trade Time Type Quantity Stock Price Currency
20:00:00 202 $ 4.20 USD

Armata Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 78.55M 18.70M 5.31M $ - $ - -2.66 -2.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Armata Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ARMP Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.994.994.154.657,939-0.79-15.83%
1 Month5.656.304.155.1829,264-1.45-25.66%
3 Months3.2010.483.205.1954,6711.0031.25%
6 Months3.1810.482.564.4839,3141.0232.08%
1 Year3.4510.482.564.1928,3880.7521.74%
3 Years4.9010.482.454.2354,002-0.70-14.29%
5 Years4.9010.482.454.2354,002-0.70-14.29%

Armata Pharmaceuticals Description

Armata Pharmaceuticals Inc is a clinical-stage biotechnology company focused on improving human health through the development of novel natural and synthetic bacteriophage-based therapies to treat multidrug-resistant bacterial infections and preventable infectious diseases of the microbiome. Its product candidate, AP-SA01, targets Staphylococcus aureus including multidrug-resistant strains.

Your Recent History
Armata Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.